Laser therapy in the treatment of diabetic retinopathy and diabetic macular edema

LA Everett, YM Paulus - Current diabetes reports, 2021 - Springer
Abstract Purpose of Review This review highlights indications and evidence on laser
therapy in the management of diabetic retinopathy and diabetic macular edema. Particular …

Persistent diabetic macular edema: Definition, incidence, biomarkers, and treatment methods

OA Sorour, ES Levine, CR Baumal, AG Elnahry… - Survey of …, 2023 - Elsevier
Intravitreal antivascular endothelial growth factor (anti-VEGF) treatment has drastically
improved the visual and anatomical outcomes in patients with diabetic macular edema …

The impact of COVID-19 on diabetic retinopathy monitoring and treatment

I Ahmed, TYA Liu - Current diabetes reports, 2021 - Springer
Abstract Purpose of Review Diabetic retinopathy (DR) is one of the leading causes of vision
loss worldwide. Although screening and early treatment guidelines for DR have significantly …

Exploration of potential novel drug targets for diabetic retinopathy by plasma proteome screening

W Yuan, W Xu, X Xu, B Qu, F Zhao - Scientific Reports, 2024 - nature.com
The aim of this study is to identify novel potential drug targets for diabetic retinopathy (DR). A
bidirectional two-sample Mendelian randomization (MR) analysis was performed using …

Modifications of intravitreal injections in response to the COVID-19 pandemic

CC Weng, TY Lin, YP Yang, YJ Hsiao… - Journal of the …, 2021 - journals.lww.com
Abstract The Coronavirus disease 2019 (COVID-19) pandemic has caused unprecedented
disruption to the normal operation of the healthcare system. On a worldwide scale, hospitals …

Reasons for Delayed Anti-VEGF Treatment During COVID-19 Lockdown and Clinical Impact in Neovascular Age-Related Macular Degeneration

J Zarranz-Ventura, JJ Escobar-Barranco… - Ophthalmology and …, 2023 - Springer
Introduction Timely anti-vascular endothelial growth factor (VEGF) treatment is crucial for
visual function in neovascular age-related macular degeneration (nAMD). The aim of this …

Effects of delay in anti-vascular endothelial growth factor intravitreal injections for neovascular age-related macular degeneration

J Hanhart, R Wiener, H Totah, E Gelman… - Graefe's Archive for …, 2022 - Springer
Purpose To assess the impact of COVID-19-related delay in intravitreal injection timing on
macular structure and visual acuity (VA) among patients treated for neovascular age-related …

Intravitreal injection planning during COVID-19 pandemic: A retrospective study of two tertiary university centers in Italy

D Mazzuca, G Demarinis, M Della Corte, F Caputo… - Healthcare, 2023 - mdpi.com
The COVID-19 pandemic has hampered the optimum management of retinal diseases. This
study examined the impact of the pandemic on the intravitreal-injection practice in two …

The impact of non-ophthalmic factors on intravitreal injections during the COVID-19 lockdown

S Ashrafzadeh, BS Gundlach, I Tsui - Clinical Ophthalmology, 2021 - Taylor & Francis
Purpose Early on in the COVID-19 pandemic, it was difficult to know what factors would
affect patient and physician decision-making regarding ophthalmic care utilization. The …

Outcome of patients treated by intravitreal injections during the COVID-19 lockdown: an institutional experience

G Sukkarieh, S Bonnin, G Azar, J Lafolie… - Current Eye …, 2023 - Taylor & Francis
Purpose To determine the loss of follow-up ratio and reasons during the COVID-19
lockdown in patients with retinal diseases treated by anti-vascular endothelial growth factor …